PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50124C00058Mach32- development of intramuscular tranexamic — Mach32 Inc

Mach32 Inc holds $750K across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Nov 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Mach32 Inc

Recipient

Nov 30, 2026

PoP end

$750K

Obligated

$750K

Potential

541714

NAICS

AN13

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Mach32 Inc — $90

Contract facts

NONE

Contract number75A50124C00058

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentMach32 Inc

CAGEL0U38

UEID87PGSR296X1

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN13

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

Related solicitationBAA-20-SOL-0002

PoP startSep 27, 2024

PoP end (current)Nov 30, 2026

Obligated$750K

Current value$750K

Potential value$750K

MACH32- DEVELOPMENT OF INTRAMUSCULAR TRANEXAMIC ACID FORMULATION is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Mach32 Inc. Estimated value $750K ($750K obligated). Current period of performance ends Nov 30, 2026. Last award drew 1 bidder. Related solicitation BAA-20-SOL-0002.

MACH32- DEVELOPMENT OF INTRAMUSCULAR TRANEXAMIC ACID FORMULATION

Recompete timing

Public

● Expiring in 84 days

Current PoP ends Nov 30, 2026 (84 days remaining). Agencies typically plan 12–18 months ahead — at 2.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Mach32 Inc — $750K obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$750K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50124C00058?

75A50124C00058 (Mach32- development of intramuscular tranexamic) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $750K, currently held by Mach32 Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50124C00058?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50124C00058 to Mach32 Inc (potential $750K).

Who is the incumbent on 75A50124C00058?

Mach32 Inc is the incumbent with $750K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Nov 30, 2026.

When does Mach32 Inc’s 75A50124C00058 come up for recompete?

SCOUT tracks a period-of-performance end of Nov 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75A50124C00058 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Mar 2, 2026